Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/01/19 → 31/12/20 |
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Mild to Moderate Alzheimer's Disease.
- O'Brien, Terence (Primary Chief Investigator (PCI))
Project: Research